IVNS1ABP Activators
Influenza Virus NS1A Binding Protein (IVNS1ABP) is a protein encoded by the IVNS1ABP gene in humans. As its name suggests, the protein was initially identified due to its ability to bind to the NS1 protein of the influenza A virus.The NS1 protein of influenza A is a multifunctional protein that interferes with the host's immune response, enhancing the virus's ability to replicate and cause disease. By binding to NS1, IVNS1ABP may influence the lifecycle of the influenza A virus within host cells, although the exact implications of this interaction are not fully understood.
Beyond its interaction with influenza, IVNS1ABP is also known to participate in several essential cellular processes in the host. Notably, it is involved in the regulation of cell division, acting as a component of the mitotic spindle, the structure that segregates chromosomes during cell division.IVNS1ABP also plays a role in the regulation of gene expression. It is a component of the nuclear pore complex, a structure that controls the transport of molecules between the nucleus and cytoplasm. This position allows IVNS1ABP to influence the transport of RNA and proteins, and thus, gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly increases cAMP levels, indirectly enhancing the activity of IVNS1ABP by promoting PKA-mediated phosphorylation, a process crucial for modulating its function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a non-specific phosphodiesterase inhibitor, elevates intracellular cAMP levels, indirectly influencing IVNS1ABP activity by altering PKA-dependent phosphorylation processes. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective phosphodiesterase-4 inhibitor, raises cAMP levels, thereby affecting IVNS1ABP activity through PKA-mediated signaling pathways. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide, a selective inhibitor of phosphodiesterase-3, increases cAMP levels, indirectly modulating IVNS1ABP function via PKA-dependent pathways. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone, a potent phosphodiesterase-3 inhibitor, enhances cAMP levels, thereby indirectly influencing IVNS1ABP activity through PKA-mediated signaling cascades. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, primarily known for inhibiting phosphodiesterase-5, also elevates cAMP levels, affecting IVNS1ABP through PKA-dependent mechanisms. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxyfilline, a phosphodiesterase inhibitor, increases cAMP levels, thereby indirectly modulating IVNS1ABP activity via PKA-mediated pathways. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Dipyridamole, known for its antiplatelet activity, also increases cAMP by inhibiting phosphodiesterase, indirectly affecting IVNS1ABP via PKA-mediated signaling. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, a non-selective phosphodiesterase inhibitor, elevates cAMP levels, thus indirectly influencing IVNS1ABP activity through PKA-dependent pathways. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, a well-known stimulant, indirectly affects IVNS1ABP activity by inhibiting phosphodiesterase enzymes, leading to increased cAMP levels and PKA-mediated signaling. | ||||||